By Brian Kitzerow, PT, DPT, OCS, CMPT

 

If you’re living in Calgary and dealing with symptoms related to Ehlers-Danlos Syndrome (EDS), hypermobility, or Postural Orthostatic Tachycardia Syndrome (POTS), you’re not alone—and effective physiotherapy options are available. Many people with EDS and POTS experience dizziness, fatigue, brain-fog, pain, and difficulty tolerating daily activities, yet struggle to find clear answers.

 

At our Calgary physiotherapy clinic, we see a growing number of patients with POTS and hypermobility-related dysautonomia, and one of the most important steps is understanding how these conditions work and why they create such widely varying symptoms. The more you understand your own physiology, the easier it becomes to manage POTS confidently and reclaim your daily function. If you would like to learn more keep reading!

 

Postural Orthostatic Tachycardia Syndrome (POTS) is a complex and often misunderstood condition that can produce a wide range of symptoms—most commonly dizziness, headaches, tremors, disorientation, fatigue, and brain fog. Our understanding of POTS continues to evolve quickly, and so does the way we diagnose and manage it. 

 

There can be many different causes contributing to the presentation of POTS.  Multiple studies have demonstrated that some people with POTS experience reduced blood flow to the brain when upright.¹²³⁴⁵⁶ Other research shows that not all POTS patients follow the same pattern—some maintain normal cerebral blood flow.⁷⁸⁹¹⁰¹¹¹²¹³  Others showed reduced intracranial blood flow in patients without high heart rate (tachycardic) or low blood pressure (hypotensive abnormalities).  These differences highlight something essential: POTS is not one condition, but a group of related conditions with different mechanisms.  

 

Additionally, classifications for types of POTS are continuing to evolve and change.  Most researchers support roughly 7 different types with a lot of crossovers between them. Because of this heterogeneity, each POTS patient must be treated as an individual with consciously identified treatment protocols and educational materials.  Treatments that may be useful for a patient with Secondary POTS (related to Ehlers-Danlos and hypermobility syndromes) may not be useful for Mast-cell Mediated POTS.  And what about the patient with elements of both Secondary and Mast-cell Mediated vs the isolated single-type patient.  It’s not uncommon to see patients with elements of at least 4 of the different types in a single presentation.    

 

As an educated provider the complexity of POTS causes and presentations can be extremely challenging to understand and design treatments for.  But as a patient it is exponentially harder to pick through the confusion.  Layer onto this that patients commonly experience these symptoms for much of their life and identifying which symptoms are relevant abnormalities from those that are normal experiences to the general population is very challenging.  Many people with POTS don’t realize that things like purple feet in the shower, needing to sit to towel off, morning fasting tendencies, or brief dizzy spells are not typical experiences. 

Because there is such a wide-range of causes, presentations and deficits we will only be discussing self-care techniques generally.  Not all of these will be relevant to all POTS patients and some might conceivably worsen POTS on occasion.  Keep in mind that not all of these tips might help everyone.  Therefore, it can be very helpful to get in with an educated provider to discuss self-care options that are right for you and how your particular POTS experience presents.   

How many people have POTS?   

 

We still don’t know the true prevalence. 

 

  • In the early 2010s, estimates suggested a minimum prevalence of 0.17% (170 per 100,000), while acknowledging significant under-recognition.¹⁶
  • By the 2020s, expert reviews commonly cited 0.2% to 1% of the population, reflecting both better diagnosis and a probable true increase—especially after COVID-19.¹⁷

 

Regardless of the exact number, the trend is clear: POTS is far more common than previously recognized, and improving diagnostic recognition is essential. 

 

Who Should Diagnose and Treat POTS? 

 

There is no single specialty that “owns”  the treatment and diagnosis of POTS. 

 

POTS is multi-system, much like hypermobility syndromes, and doesn’t fit neatly into cardiology, neurology, rheumatology, or internal medicine. 

 

A 2022 survey by Cooperrider et al. found that: 

 

  • 81% of POTS diagnoses were made by neurologists, 
  • followed by cardiologists, primary care physicians, and others.¹⁸

 

However, in real clinical practice, any MD who has knowledge and interest in dysautonomia can diagnose POTS. Geneticists, rheumatologists, and even naturopathic physicians often identify cases. 

 

There are currently no studies comparing which profession is best positioned to treat POTS. Many patients receive medication through their PCP or cardiologist, while a large percentage are referred to physiotherapy. 

 

Physiotherapy is ideally placed to treat POTS because the most effective interventions—graded exercise, autonomic retraining, breathing pattern correction, functional pacing, and strength conditioning—are intrinsically rehabilitative. While cardiologists and neurologists diagnose POTS, physiotherapists provide the core therapy that restores orthostatic tolerance, increases stroke volume, improves autonomic stability, and allows patients to return to meaningful activity. 

Watch Your Heart Rate 

 

It is common for people with POTS to see a large rise in heart rate upon standing. Diagnostic criteria typically include: 

 

  • an increase of ≥30 bpm within 10 minutes of upright posture. ¹⁹

 

Most people without POTS experience only a 10–20 bpm increase. For reference, a standing heart rate of 120 bpm is similar to going for a light jog. 

 

If your heart rate rises from 65 bpm lying down to 120 bpm standing, you are likely experiencing a POTS episode. 

 

A lot of people with POTS have learned to function in this range.  Many aren’t even aware that they are having unreasonably high heart rates.   Checking your HR or having your biometric devices set to give you alarms if it exceeds certain parameters can be very helpful for heading off POTS episodes early, before they impact your day.²⁰ Apple watches and Garmin can be expensive, but a simple pulse oximeter can be purchased off Amazon for under $30.   

What Can You Do to Improve Blood Flow to the Brain? 

 

Not all strategies help every subtype, but most people benefit from a combination of positioning, hydration, salt intake, compression, and exercise. 

 

  1. Positioning

 

Most POTS subtypes show reduced blood flow to the brain when upright.
Getting the head and heart on the same level improves perfusion. 

 

Lying flat for short breaks throughout the day can give your brain the oxygen boost it needs. 

 

  1. Salt and Hydration

 

Increasing blood volume helps the cardiovascular system function more effectively in POTS. Hydration + electrolytes can improve cerebral circulation. 

 

Important notes: 

 

  • Avoid this strategy if you have hypertension, particularly in hyperadrenergic or mast-cell–related POTS. 
  • Avoid drinking large volumes of water without salt—this can dilute electrolytes and lower blood pressure. 
  • Salt dosing should be guided by your physician, as excessive electrolytes can affect heart function and may not be appropriate for everyone 

 

  1. Compression

 

Compression helps push blood upward, improving brain perfusion. 

 

Options include: 

 

  • compression socks (20–30 mmHg or ideally 30–40 mmHg if tolerated) 
  • leggings 
  • specialized garments like Intelliskin, SKINS, or Supacore 

 

Even inexpensive socks can make a meaningful difference. 

 

  1. Exercise

 

Your body always maintains a certain level of compression on itself, from both mass and elastic components.  A cool term for this is tensegrity.  The passive tensegrity in hypermobile patients is lower than the normal population and this can contribute to POTS.  While passive tensegrity isn’t something you have much control over, active tensegrity is in your muscle mass and tone (the amount of tension a muscle rests at).  And that you can control.   

 

Building muscle improves: 

 

  • vascular responsiveness 
  • venous return 
  • tolerance to upright activities! 

 

Start at a level that does NOT trigger POTS.

One thing that is commonly missed by younger physios, if walking provokes symptoms, standing exercise will likely make things worse. 

 

A typical progression: 

 

  1. supine (on back, stomach, or side) 
  2. semi-recumbent 
  3. sitting 
  4. standing 

 

There is also evidence that causes us to suspect that the cardiac benefits from exercise, heart stroke volume and blood volume, can lower POTS symptoms.²¹ We also suspect that we can modulate sympathetic responses including autonomic nervous system and vagal responses through careful exercise progressions. 

 

Other interventions that we are watching and implementing on a more limited basis due to the low number of studies and unclear efficacy include Baroreflex conditioning, breath training for hypocapnia, time restricted caloric windows, cooling protocols and anti-inflammatory lifestyles.  

 

Living with POTS can feel overwhelming, but it becomes far more manageable once you understand your specific patterns, triggers, and physiology. There is no single pathway through POTS, but there are consistent strategies that help many people regain stability, confidence, and control over their day. With education, pacing, the right exercise progression, and support from clinicians who understand dysautonomia, most patients make meaningful improvements in function and quality of life. You do not have to navigate POTS alone—there are effective tools, and there is a way forward. 

 

References

 

1. Ocon AJ, Medow MS, Taneja I, Clarke D, Stewart JM. Decreased upright cerebral blood flow and cerebral autoregulation in normocapnic postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2009;297(2):H664-H673. doi:10.1152/ajpheart.00138.20092. Medow MS, Del Pozzi AT, Messer ZR, Terilli C, Stewart JM. Altered oscillatory cerebral blood flow velocity and autoregulation in postural tachycardia syndrome. Front Physiol. 2014;5:234. doi:10.3389/fphys.2014.002343. Del Pozzi AT, Schwartz CE, Tewari D, Medow MS, Stewart JM. Reduced cerebral blood flow with orthostasis precedes hypocapnic hyperpnea, sympathetic activation, and postural tachycardia syndrome. Hypertension. 2014;63(6):1302-1308. doi:10.1161/HYPERTENSIONAHA.113.02824
4. Novak V, Novak P, Spies JM, Low PA. Hypocapnia and cerebral hypoperfusion in orthostatic intolerance. Stroke. 1998;29(9):1876-1881. doi:10.1161/01.str.29.9.1876
5. Novak P. Cerebral blood flow, heart rate, and blood pressure patterns during the tilt test in common orthostatic syndromes. J Neurol Sci. 2016;362:41-46. doi:10.1016/j.jns.2016.01.035
6. van Campen CM, Rowe PC, Visser FC. Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: a quantitative, controlled study using Doppler echography. Clin Neurophysiol Pract. 2020;5:50-58. doi:10.1016/j.cnp.2019.11.003
7. Stewart JM, Montgomery LD, Glover JL, Medow MS. Changes in regional blood volume and cerebral blood flow during orthostasis in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2004;287(3):H1319-H1327. doi:10.1152/ajpheart.01138.2003
8. Stewart JM, Medow MS, Messer Z, et al. Postural hyperventilation: a frequent and overlooked cause of orthostatic intolerance. Am J Physiol Heart Circ Physiol. 2012;302(1):H166-H173. doi:10.1152/ajpheart.00330.2011
9. Jordan J, Shannon JR, Grogan E, et al. Contrasting effects of vasovagal syncope and POTS on cerebral blood flow. Circulation. 2003;108(3):284-289. doi:10.1161/01.CIR.0000079173.07574.D3
10. Stewart JM, Montgomery LD, Glover JL, Medow MS. Changes in regional blood volume and cerebral blood flow during orthostasis in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol. 2004;287(3):H1319-H1327. doi:10.1152/ajpheart.01138.2003
11. Stewart JM, Medow MS, Messer Z, et al. Postural hyperventilation: a frequent and overlooked cause of orthostatic intolerance. Am J Physiol Heart Circ Physiol. 2012;302(1):H166-H173. doi:10.1152/ajpheart.00330.2011
12. Jordan J, Shannon JR, Grogan E, et al. Contrasting effects of vasovagal syncope and POTS on cerebral blood flow. Circulation. 2003;108(3):284-289. doi:10.1161/01.CIR.0000079173.07574.D3
13. Novak V, Novak P, Spies JM, Low PA. Hypocapnia and cerebral hypoperfusion in orthostatic intolerance. Stroke. 1998;29(9):1876-1881. doi:10.1161/01.STR.29.9.1876
14. Bryarly M, Phillips LT, Fu Q, Vernino S, Levine BD. Postural Orthostatic Tachycardia Syndrome: JACC Focus Seminar. J Am Coll Cardiol. 2019;73(10):1207-1228. doi:10.1016/j.jacc.2018.11.059
15. Olshansky B, Sullivan RM, Inayat F, et al. Postural Orthostatic Tachycardia Syndrome: A Critical Assessment. Prog Cardiovasc Dis. 2020;63(3):263-273. doi:10.1016/j.pcad.2020.01.003
16. Mathias CJ, Low DA, Iodice V, et al. Postural tachycardia syndrome—current experience and concepts. Nat Rev Neurol. 2012;8(1):22-34. doi:10.1038/nrneurol.2011.187
17. Vernino S, Bourne KM, Stiles LE, et al. Postural orthostatic tachycardia syndrome: state of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting. Neurology. 2021;97(16):e160-e171. doi:10.1212/WNL.0000000000012759
18. Cooperrider J, Kriegler J, Yunus S, Wilson R. A survey-based study examining differences in perception of postural orthostatic tachycardia syndrome between patients and primary care physicians. Cureus. 2022;14(11):e31531. doi:10.7759/cureus.31531
19. Raj SR, Fedorowski A, Sheldon RS. Diagnosis and management of postural orthostatic tachycardia syndrome. CMAJ. 2022;194(10):E378-E385. doi:10.1503/cmaj.211373
20. Finkelstein J, Gabriel N, et al. A wearable solution for managing postural orthostatic tachycardia syndrome: patient perspectives on real-time heart rate monitoring and activity pacing. J Med Internet Res. 2025;27(2):eXXXXX. doi:10.2196/XXXXX
21. Fu Q, Vangundy TB, Shibata S, Auchus RJ, Williams GH, Levine BD. Exercise in the postural orthostatic tachycardia syndrome. J Am Heart Assoc. 2014;3(1):e000067. doi:10.1161/JAHA.113.000067

 

About the Author:

Brian Kitzerow, hypermobility expert, is photoshopped riding a zebra on a safari.

Brian Kitzerow, PT, DPT, OCS, CMPT, is a new physiotherapist in Calgary with specialized expertise in hypermobility, Ehlers-Danlos Syndrome (EDS), dysautonomia/POTS, and complex pain conditions. With more than 15 years of clinical experience and advanced orthopedic credentials, Brian integrates biomechanics, pain science, and nervous-system regulation to help patients build stability, strength, and long-term resilience. He is dedicated to providing clear education, evidence-based treatment, and supportive care for individuals who often feel misunderstood in traditional medical settings.

By Brian Kitzerow, PT, DPT, OCS, CMPT

 

Pain in hypermobility is real, explainable, and treatable. Highly flexible people can sometimes have a large amount of pain but have a very difficult time finding care and support to treat their discomfort. Their doctors might not be able to identify any causes for the pain and this can lead to feelings of alienation and inadequacy. This isn’t necessarily because there isn’t anything wrong with them, but more commonly it is because medical clinics don’t have the same tools our research labs have to identify dysfunctions that cause the pain.  X-rays and MRIs are excellent for major structural injuries, but they cannot detect dysfunction at the level of nociceptors, small fibers, proprioceptors, or subtle instability.

 

Likewise, pain in hypermobility isn’t simple—and it isn’t easily communicated. Like the experience of seeing color, pain is highly individualized. Two people can look at the same object and agree that it’s red, yet their internal experience of ‘redness’ is shaped by their biology, past experiences, and neural wiring.

 

Additionally, pain in hypermobility arises from many different pathways, not just “loose joints.” Contributing factors may include:

 

  • Immune reactivity or autoimmune overlap
  • Increased muscle, tendon, and ligament strain
  • Central sensitization
  • Dysautonomia / POTS
  • Small fiber neuropathy
  • Peripheral nerve strain
  • Brainstem and spinal cord stress
  • Sleep disruption
  • Hormonal cycling
  • Dietary triggers
  • Psychological stress

 

That’s a big list and it can be very difficult to negotiate that experience on your own.

 

Hypermobility vs Hypermobile Spectrum Disorders

 

Hypermobility alone is not a disorder. Hypermobile joints are a normal variation of the human population. Like Yin and Yang you cannot define a person as stiff without having the contrast of loose. The evolution of individuals with “looser” musculoskeletal systems brings with it certain hypothetical advantages that have maintained the genetic expression in our population. But with these advantages come risks.

 

Likewise, unlike disorders caused by single-gene mutations, hypermobility appears to arise from complex interactions among multiple genes.  A characteristic of genetic diseases is that a defect in a single or small number of genes can cause the function of the body to fall off the rails. In Marfan’s it is FBN-1.[i]  In Vascular EDS it is COL3A1.[ii]  Classical EDS is associated with COL5A1 or COL5A2.[iii]  Hypermobility, in contrast, is suspected to arise from interactions among multiple genes, although the exact genes remain unidentified. This suggests an evolutionary trend towards specific physical attributes rather than an accidental mutation.

 

We still do not have a strong consensus on how prevalent hypermobility is in the population.  Opinions vary wildly with Blajwajs reporting that the number lies between 2 and 57% of the population being hypermobile.[iv]  That’s a massive range with a great deal of uncertainty.

 

Some studies have looked at hypermobility in segments of our population[v][vi], but clarity on the entire population remains undefined. A synthesis of publications in the last 10 years on adults with a Beighton scale of >4/9 suggests a consensus of 16-22% of the population.[vii]  An estimated one fifth of the population does not suggest an accidental genetic disease.

 

Hypermobility becomes a dysfunction rather than a normal presentation of a population when symptoms appear.  Pain, dislocation, challenges with stability, fatigue, headache, etc.  Again, the causes of symptoms developing are not homogenous across hypermobile populations and can arise from a multitude of causes and interactions.

 

Pain presentation models like Scott Dye’s Envelope of Function[i] or Michael Turvey’s Tensegrity hypothesis[ii] are both deep dives, but highly powerful models for understanding when and why hypermobility raises the risks for transitioning from the healthy athlete to developing debilitating symptoms.

 

A Slice of Pain Generators

 

Ok, you’ve suffered through all the heavy theory. It’s time to get into relevant advice.  Let’s look at four common causes of pain in hypermobility and what you can do about it. Keep in mind that most of these are models and are subject to change as our understanding evolves.

 

Micro-Instability

 

Hypermobile joints have challenges “locking-in” to stable end-ranges. To compensate for this, the muscles in hypermobile individuals work harder to maintain neutral postures for sitting and standing. You might have noticed that it is easier for you to maintain standing positions by shifting around rather than standing at attention stiffly like other people can. This places more strain on the muscle and tendon structures and is more energy intensive.

 

Muscle strength is essential to compensate for this lack of stability. Deconditioning brings pain. Bracing can also be helpful.

 

Proprioception

 

We don’t know exactly why, but people with hypermobility have more challenges with proprioception. The decrease in end-range joint stability is almost certainly a contributor, but there are likely other causes that are being investigated as well.

 

We do know that when the brain has challenges identifying joint position it responds by increasing the protective tone that muscles rest at. This leads to stiffness, spasms and trigger points, even when you are at rest.

 

Helping your brain to know where your joints are can reduce these experiences. Weighted blankets, braces, tape, compressive clothing can all reduce energy expenditures and improve comfort.  Somewhat counter-intuitively, exercise is extremely helpful to reduce this muscle stiffness. The more fit your muscles are the better they can maintain both joint stability and neurosensory tone.

 

Tendon and Ligament Strain

 

Building on the first two factors, tendons and ligaments can experience more strain in a hypermobile system. The decreased end range stability and proprioception results in larger amplitude sway and delayed stabilization responses that increase strain on the tissues anchoring muscles and joints. This repeated low-grade strain often does not show up on imaging but still produces real pain.

 

Training and measures to protect those tissues can reduce the localized inflammation and pain.  Again, bracing and taping is helpful. Increased muscular tone is also important. Finally, proprioceptive balance training can improve your ability to protect these tissues.

 

Central Sensitization

 

Pain is an adaptive experience that changes as we are exposed to different experiences, environments, stressors and stimuli. Research shows that we develop stronger neural pathways in the brain to experience pain when we regularly stimulate a particular pain pathway. This results in a lowered threshold for the nervous system to generate a pain response in association with that tissue. Occasionally these thresholds become low enough that a stress that causes no damage on the tissue level is experienced as excruciating pain.

 

Sometimes this is likened to the phenomenon of listening to music at higher or lower levels.  After a short time, your brain adapts to the volume and you experience it in a normalized, mid-range. Pain pathways however are much more resilient and slower to adapt.

 

This does not mean that your pain is not real. It is very observable with brain imaging when a person is in pain. But it does mean that your nervous system is very skilled at creating a pain experience and that it would be more functional if the degree of stimulus to create a pain experience was more aligned with the degree of stimulus to cause tissue damage.  Correct calibration would not only be less painful, but would help you to make better choices on what activities are risking tissue failure and which are not to prevent injury.

 

Central sensitization can be challenging to correct but we have solid research from clinicians like David Butler and Lorimer Mosely on pathways to correct it in the clinic.[i]

 

These are only a small sample of the different and highly complex mechanisms responsible for pain experiences in hypermobility.

 

 

With the right strategies, hypermobile bodies become stronger, more stable, and far less painful.

 

Evidence-based physiotherapy, pain education, strength training, and nervous-system regulation can dramatically improve comfort, function, and confidence.

 

If you’re living with hypermobility and pain, you’re not alone—and there is a clear, science-backed path forward.

 

References

 

[I] Dietz HC. Marfan Syndrome. In: Adam MP, Mirzaa GM, Pagon RA, et al., eds. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993–2024. Updated 2017.

[II] Murray ML, Pepin M, Byers PH. Vascular Ehlers-Danlos Syndrome. In: Adam MP, Mirzaa GM, Pagon RA, et al., eds. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993–2024. Updated 2014.

[III] Malfait F, Wenstrup RJ, De Paepe A. Classic Ehlers-Danlos Syndrome. In: Adam MP, Mirzaa GM, Pagon RA, et al., eds. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993–2024. Updated 2017.

[IV] Blajwajs L, Williams J, Timmons W, Sproule J. Hypermobility prevalence, measurements, and outcomes in childhood, adolescence, and emerging adulthood: a systematic review. Rheumatol Int. 2023 Aug;43(8):1423-1444. doi: 10.1007/s00296-023-05338-x. Epub 2023 May 6. PMID: 37149553; PMCID: PMC10261186.

[V] Russek LE, Errico DM. Prevalence, injury rate, and symptom frequency in generalized joint laxity and joint hypermobility syndrome in a “healthy” college population. Clin Rheumatol. 2016;35(4):1029-1039.

[VI] Reuter PR, Fichthorn KR. Prevalence of generalized joint hypermobility, musculoskeletal injuries, and chronic musculoskeletal pain among American university students. PeerJ. 2019;7:e7625.

[VII] OpenAI. ChatGPT: Analysis of recent studies on generalized joint hypermobility prevalence in adult populations. December 2025. Accessed [date]. Available from: https://chat.openai.com

[VIII] Dye SF. The knee as a biologic transmission with an envelope of function. Clin Orthop Relat Res. 1996;(325):10-18.

[IX] Turvey MT, Fonseca ST. The medium of haptic perception: A tensegrity hypothesis. J Mot Behav. 2014;46(3):143-187

[X] Moseley GL, Butler DS. Fifteen Years of Explaining Pain: The Past, Present, and Future. J Pain. 2015;16(9):807–813

 

 

About the Author

 

Brian Kitzerow, hypermobility expert, is photoshopped riding a zebra on a safari.

 

Brian Kitzerow, PT, DPT, OCS, CMPT, is a new physiotherapist in Calgary with specialized expertise in hypermobility, Ehlers-Danlos Syndrome (EDS), dysautonomia/POTS, and complex pain conditions. With more than 15 years of clinical experience and advanced orthopedic credentials, Brian integrates biomechanics, pain science, and nervous-system regulation to help patients build stability, strength, and long-term resilience. He is dedicated to providing clear education, evidence-based treatment, and supportive care for individuals who often feel misunderstood in traditional medical settings.

 

 

Hanson Ranch Plaza

Centre Street